Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Labcorp
LH
$27.5B
| $1.71M | 0.01% |
+6,801
| New | +$1.81M |
|
927
ProShares VIX Short-Term Futures ETF
VIXY
$223M
| $1.7M | 0.01% |
+66,445
| New | +$2.11M |
|
|
CEPO
928
Cantor Equity Partners I
CEPO
$275M
| $1.7M | 0.01% |
+163,599
| New | +$1.71M |
|
929
Axcelis
ACLS
$3.81B
| $1.7M | 0.01% |
21,182
-16,455
| -44% | -$1.38M |
|
930
Tarsus Pharmaceuticals
TARS
$3.2B
| $1.69M | 0.01% |
+20,674
| New | +$1.54M |
|
931
Surrozen
SRZN
$282M
| $1.69M | 0.01% |
74,645
+5,621
| +8% | +$90.9K |
|
932
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $1.69M | 0.01% |
33,833
+540
| +2% | +$24.9K |
|
933
Monro
MNRO
$402M
| $1.68M | 0.01% |
83,616
+16,636
| +25% | +$306K |
|
934
CALL
Walmart Inc
WMT
$847B
| $1.67M | 0.01% |
15,000
| – | – |
|
|
935
PUT
Walmart Inc
WMT
$847B
| $1.67M | 0.01% |
15,000
| – | – |
|
|
BRCB
936
Black Rock Coffee Bar Inc
BRCB
$210M
| $1.67M | 0.01% |
75,000
-36,401
| -33% | -$844K |
|
937
Infosys
INFY
$47.9B
| $1.66M | 0.01% |
93,154
+53,935
| +138% | +$933K |
|
938
Floor & Decor
FND
$5.84B
| $1.64M | 0.01% |
26,984
-45,591
| -63% | -$2.96M |
|
939
SBA Communications
SBAC
$19.6B
| $1.64M | 0.01% |
8,487
-132,617
| -94% | -$25.6M |
|
940
Vera Therapeutics
VERA
$2.43B
| $1.64M | 0.01% |
32,402
-47,108
| -59% | -$1.67M |
|
|
MICC
941
The Magnum Ice Cream Company N.V.
MICC
$12.3B
| $1.64M | 0.01% |
+103,279
| New | +$1.62M |
|
942
Guidewire Software
GWRE
$16B
| $1.63M | 0.01% |
8,093
-7,458
| -48% | -$1.65M |
|
|
LAFAU
943
LaFayette Acquisition Corp Unit
LAFAU
$106M
| $1.62M | 0.01% |
+161,153
| New | +$1.62M |
|
|
TPC
944
Tutor Perini Cor
TPC
$4.64B
| $1.62M | 0.01% |
24,150
-13,429
| -36% | -$881K |
|
945
Alignment Healthcare
ALHC
$2.79B
| $1.61M | 0.01% |
81,530
+70,702
| +653% | +$1.27M |
|
946
Black Hills Corp
BKH
$5.49B
| $1.61M | 0.01% |
23,181
-61,906
| -73% | -$4.17M |
|
|
EVAC
947
EQV Ventures Acquisition Corp II
EVAC
$600M
| $1.61M | 0.01% |
160,401
+60,401
| +60% | +$605K |
|
948
VEON
VEON
$4.21B
| $1.61M | 0.01% |
+30,593
| New | +$1.55M |
|
949
Asana
ASAN
$2.25B
| $1.59M | 0.01% |
116,260
-73,876
| -39% | -$1.02M |
|
950
Intel
INTC
$461B
| $1.58M | 0.01% |
42,943
-24,517
| -36% | -$926K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.